Abbott Laboratories (ABT)
NYSE · Healthcare
Abbott Laboratories Income Statement 2007–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | Dec 2008 | Dec 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||||
| Revenue | 44.33B | 41.95B | 40.11B | 43.65B | 43.08B | 34.61B | 31.90B | 30.58B | 27.39B | 20.85B | 20.41B | 20.25B | 19.66B | 19.05B | 21.41B | 35.17B | 30.76B | 29.53B | 25.91B |
| Gross Profit | 25.01B | 23.24B | 22.13B | 24.51B | 24.54B | 19.61B | 18.67B | 17.87B | 14.98B | 11.76B | 11.66B | 11.03B | 10.46B | 10.15B | 11.39B | 20.50B | 17.56B | 16.92B | 14.49B |
| Profitability | |||||||||||||||||||
| Operating Income | 8.05B | 6.83B | 6.48B | 8.36B | 8.43B | 5.36B | 4.53B | 3.65B | 1.56B | 3.03B | 2.87B | 2.60B | 2.13B | 1.36B | 1.63B | 6.09B | 6.24B | 5.69B | 4.58B |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income | 6.52B | 13.40B | 5.72B | 6.93B | 7.07B | 4.50B | 3.69B | 2.37B | 477.0M | 1.40B | 4.42B | 2.28B | 2.58B | 5.96B | 4.73B | — | — | — | — |
| Per Share Data | |||||||||||||||||||
| EPS (diluted) | $3.72 | $7.64 | $3.26 | $3.91 | $3.94 | $2.50 | $2.06 | $1.33 | $0.27 | $0.94 | $2.92 | $1.49 | $1.62 | $3.72 | $3.01 | $2.96 | $3.69 | $3.12 | $2.31 |
| Shares Outstanding (dil.) | 1,748M | 1,748M | 1,749M | 1,764M | 1,789M | 1,786M | 1,781M | 1,770M | 1,749M | 1,483M | 1,506M | 1,527M | 1,574M | 1,592M | 1,567M | 1,556M | 1,555M | 1,561M | 1,560M |
Abbott Laboratories Income Statement — FAQ
Abbott Laboratories (ABT) income statement over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ABT's income statement history?
The chart and table above show Abbott Laboratories's income statement by year and by quarter, including the growth rate.